News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
295,753 Results
Type
Article (14129)
Company Profile (208)
Press Release (281416)
Section
Business (90351)
Career Advice (263)
Deals (18150)
Drug Delivery (26)
Drug Development (52281)
Employer Resources (33)
FDA (6339)
Job Trends (6186)
News (163610)
Policy (11864)
Tag
Academia (946)
Africa (153)
Alabama (23)
Allergies (29)
Alliances (24723)
ALS (16)
Alzheimer's disease (701)
Antibody-drug conjugate (ADC) (27)
Approvals (6310)
Arizona (51)
Artificial intelligence (21)
Asia (18487)
Australia (2975)
Bankruptcy (152)
Best Places to Work (5226)
Biosimilars (16)
C2C Services and Suppliers (16966)
California (557)
Canada (354)
Cancer (103)
Career advice (230)
CAR-T (25)
Cell therapy (55)
China (28)
Clinical research (40417)
Collaboration (40)
Colorado (17)
COVID-19 (994)
Cystic fibrosis (58)
Data (15)
Diabetes (14)
Diagnostics (1666)
Drug pricing (17)
Duchenne muscular dystrophy (15)
Earnings (31531)
Employer resources (31)
Europe (37880)
Events (50420)
Executive appointments (21)
FDA (6364)
Florida (64)
Funding (29)
Gene editing (16)
Gene therapy (46)
GLP-1 (248)
Government (1178)
Healthcare (7606)
Hotbed/Location (215206)
Idaho (23)
Illinois (50)
Indiana (51)
Infectious disease (997)
Inflammatory bowel disease (74)
Interviews (36)
IPO (9678)
Job creations (1003)
Job search strategy (209)
Kansas (51)
Layoffs (175)
Legal (2071)
Liver cancer (25)
Lung cancer (18)
Maine (31)
Maryland (128)
Massachusetts (282)
Medical device (3851)
Medtech (3851)
Mergers & acquisitions (8357)
Metabolic disorders (81)
Neuroscience (761)
New Jersey (40)
New York (48)
NextGen Class of 2024 (2615)
Non-profit (954)
North Carolina (78)
Obesity (51)
Opinion (81)
Parkinson's disease (25)
Peanut (26)
Pennsylvania (26)
People (27708)
Phase I (14062)
Phase II (18762)
Phase III (12080)
Policy (15)
Postmarket research (913)
Preclinical (5885)
Rare diseases (73)
Real estate (1810)
Regulatory (8961)
Research institute (1004)
Resumes & cover letters (30)
Series A (16)
South America (246)
Startups (2189)
Texas (33)
United States (1679)
Vaccines (104)
Washington State (75)
Weight loss (42)
Date
Today (34)
Last 7 days (278)
Last 30 days (1168)
Last 365 days (23975)
2024 (13613)
2023 (24764)
2022 (30137)
2021 (31659)
2020 (27261)
2019 (19582)
2018 (14370)
2017 (15951)
2016 (13743)
2015 (16997)
2014 (12273)
2013 (9156)
2012 (9387)
2011 (9254)
2010 (8880)
295,753 Results for "galera therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Galera Adopts Limited Duration Stockholder Rights Agreement - May 03, 2024
Galera Therapeutics, Inc. announced that its Board of Directors has unanimously resolved to adopt a limited duration stockholder rights agreement to protect stockholder interests.
May 3, 2024
·
4 min read
Business
Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesCompany’s evaluation of potential strategic alternatives progresses with goal to maximize stockholder value
Galera Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and provided recent corporate updates.
May 13, 2024
·
7 min read
Business
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
Galera Therapeutics, Inc. announced financial results for the fourth quarter and year ended December 31, 2023 and provided recent corporate updates.
March 28, 2024
·
10 min read
Business
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Galera Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2023 and provided recent corporate updates.
November 14, 2023
·
11 min read
Pharm Country
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
Galera Therapeutics, Inc. announced that it has received official meeting minutes from the Type A meeting with the United States Food and Drug Administration held September 28, 2023 in which the FDA reiterated the need for an additional Phase 3 trial of avasopasem manganese for radiotherapy-induced SOM.
October 31, 2023
·
7 min read
Genetown
Strategic Acquisition Opportunity: Biotechnology Intellectual Property of Civetta Therapeutics, LLC Now Open for Bids
The Assignee of Civetta Therapeutics, LLC, a trailblazer in the field of biotechnology with a focus on β-propeller protein research, is inviting bids for the company’s rich portfolio of intellectual property.
April 4, 2024
·
2 min read
Pharm Country
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
Galera Therapeutics, Inc. today announced that a Type A Meeting has been scheduled for September 28, 2023 with the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for the Company’s New Drug Application (NDA) for avasopasem manganese (avasopasem).
September 18, 2023
·
5 min read
Business
Galera Expands Commercial Leadership Team
Galera Therapeutics, Inc. today announced the appointment of accomplished pharmaceutical sales, market access, and commercial operations executives to Galera’s senior commercial leadership team, effective immediately.
May 1, 2023
·
11 min read
Press Releases
PANTHERx®Rare Partnering with ITF Therapeutics LLC for U.S. Distribution of DUVYZAT™
July 26, 2024
·
3 min read
Deals
INTEGRATED ONCOLOGY NETWORK ANNOUNCES THE ACQUISITION OF UROLOGY PARTNERS, LLC
Integrated Oncology Network, LLC (“ION”), a portfolio company of Silver Oak Services Partners, LLC (“Silver Oak”), today announced the acquisition of Urology Partners, LLC.
May 2, 2024
·
3 min read
1 of 29,576
Next
